Cavities are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
| PDB ID | HET | Uniprot Name | EC Number |
|---|---|---|---|
| 3p7a | P7A | Mitogen-activated protein kinase 14 |
| PDB ID | HET | Uniprot Name | EC Number | Cavity Similarity |
Align |
|---|---|---|---|---|---|
| 3p7a | P7A | Mitogen-activated protein kinase 14 | / | 1.000 | |
| 1kv2 | B96 | Mitogen-activated protein kinase 14 | / | 0.644 | |
| 3o8u | BMU | Mitogen-activated protein kinase 14 | / | 0.643 | |
| 3p7b | P7B | Mitogen-activated protein kinase 14 | / | 0.631 | |
| 3uvr | 06F | Mitogen-activated protein kinase 14 | / | 0.620 | |
| 3p7c | P7C | Mitogen-activated protein kinase 14 | / | 0.608 | |
| 2yis | YIS | Mitogen-activated protein kinase 14 | / | 0.605 | |
| 3hv6 | R39 | Mitogen-activated protein kinase 14 | / | 0.581 | |
| 1kv1 | BMU | Mitogen-activated protein kinase 14 | / | 0.573 | |
| 3gcu | R48 | Mitogen-activated protein kinase 14 | / | 0.538 | |
| 4l8m | F46 | Mitogen-activated protein kinase 14 | / | 0.525 | |
| 4eh9 | 0OQ | Mitogen-activated protein kinase 14 | / | 0.518 | |
| 1wbs | LI2 | Mitogen-activated protein kinase 14 | / | 0.515 | |
| 1wbt | WBT | Mitogen-activated protein kinase 14 | / | 0.511 | |
| 1wbv | LI3 | Mitogen-activated protein kinase 14 | / | 0.507 | |
| 3nnw | EDD | Mitogen-activated protein kinase 14 | / | 0.502 | |
| 3nnx | EDD | Mitogen-activated protein kinase 14 | / | 0.502 | |
| 3npc | B96 | Mitogen-activated protein kinase 9 | 2.7.11.24 | 0.500 | |
| 3nnu | EDB | Mitogen-activated protein kinase 14 | / | 0.494 | |
| 3p5k | P5K | Mitogen-activated protein kinase 14 | / | 0.486 | |
| 3d83 | GK6 | Mitogen-activated protein kinase 14 | / | 0.484 | |
| 3hv4 | L51 | Mitogen-activated protein kinase 14 | / | 0.480 | |
| 1wbn | L09 | Mitogen-activated protein kinase 14 | / | 0.479 | |
| 3lff | Z83 | Mitogen-activated protein kinase 14 | / | 0.478 | |
| 3gcv | SS6 | Mitogen-activated protein kinase 14 | / | 0.475 | |
| 2e2b | 406 | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.467 | |
| 1wbw | LI4 | Mitogen-activated protein kinase 14 | / | 0.457 | |
| 3wze | BAX | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.457 | |
| 2yiw | YIW | Mitogen-activated protein kinase 14 | / | 0.456 | |
| 3hv7 | 1AU | Mitogen-activated protein kinase 14 | / | 0.456 | |
| 4fic | 0UL | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.453 | |
| 1rfq | LAR | Actin, alpha skeletal muscle | / | 0.448 | |
| 3vhe | 42Q | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.448 | |
| 4fp9 | SAM | 5-methylcytosine rRNA methyltransferase NSUN4 | 2.1.1 | 0.448 | |
| 1w82 | L10 | Mitogen-activated protein kinase 14 | / | 0.447 | |
| 2hiw | 7MP | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.444 | |
| 3c7q | XIN | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.444 | |
| 3sgx | 0FW | Ditrans,polycis-undecaprenyl-diphosphate synthase ((2E,6E)-farnesyl-diphosphate specific) | 2.5.1.31 | 0.444 | |
| 3r7y | Z04 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.443 | |
| 5hid | B1E | Serine/threonine-protein kinase B-raf | 2.7.11.1 | 0.442 | |
| 3dfc | ANP | Death-associated protein kinase 1 | 2.7.11.1 | 0.440 |